| Net Cash Provided by (Used in) Operating Activities |
$249,900,000 |
USD |
5.8% |
Q2 2025 |
Q2 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$59,500,000 |
USD |
-200% |
Q2 2025 |
Q2 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$198,800,000 |
USD |
22% |
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$7,900,000 |
USD |
-120% |
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$78,200,000 |
USD |
-40% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$70,800,000 |
USD |
-27% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Valuation Allowance |
$318,700,000 |
USD |
13% |
Q4 2025 |
FY 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.265 |
pure |
0% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Gross |
$1,080,800,000 |
USD |
-6.3% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability |
$10,500,000 |
USD |
-1.9% |
Q4 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$36,200,000 |
USD |
-85% |
Q2 2025 |
Q2 2025 |
| Property, Plant and Equipment, Gross |
$11,811,300,000 |
USD |
5.7% |
Q4 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$91,000,000 |
USD |
120% |
Q2 2025 |
Q2 2025 |
| Current Income Tax Expense (Benefit) |
$3,600,000 |
USD |
-57% |
Q2 2025 |
Q2 2025 |
| Additional Paid in Capital |
$14,700,000 |
USD |
23% |
Q4 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$107,000,000 |
USD |
4.3% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$762,100,000 |
USD |
-13% |
Q4 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$5,172,000 |
USD |
62% |
Q2 2024 |
Q2 2024 |
| Interest Expense |
$67,800,000 |
USD |
-27% |
Q2 2025 |
Q2 2025 |